chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: the tissue feels really weird/uncomfortable; Tissue at the injection site feels hard; Injection site itchy; rash at the injection site the size of a base ball; injection site the size of a base ball and the tissue feels really weird its red,; Injection site burns; swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball) and VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball), VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,), VACCINATION SITE PAIN (Injection site burns) and VACCINATION SITE SWELLING (swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball), VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,), VACCINATION SITE PAIN (Injection site burns) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: the tissue feels really weird/uncomfortable; Tissue at the injection site feels hard; Injection site itchy; rash at the injection site the size of a base ball; injection site the size of a base ball and the tissue feels really weird its red,; Injection site burns; swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball) and VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball), VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,), VACCINATION SITE PAIN (Injection site burns) and VACCINATION SITE SWELLING (swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (the tissue feels really weird/uncomfortable), VACCINATION SITE INDURATION (Tissue at the injection site feels hard), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (rash at the injection site the size of a base ball), VACCINATION SITE ERYTHEMA (injection site the size of a base ball and the tissue feels really weird its red,), VACCINATION SITE PAIN (Injection site burns) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Malaise, Nausea
Clinical narrative: Shortness of breath; Feeling pretty off and Generally feeling sick; Zero energy; Coughing; Queasy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) and MALAISE (Feeling pretty off and Generally feeling sick) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath) and MALAISE (Feeling pretty off and Generally feeling sick). At the time of the report, DYSPNOEA (Shortness of breath) and MALAISE (Feeling pretty off and Generally feeling sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Low grade fever of 99 degrees; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever of 99 degrees) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PYREXIA (Low grade fever of 99 degrees) and HEADACHE (Headache). At the time of the report, PYREXIA (Low grade fever of 99 degrees) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: sore arm; swollen arm; Pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), PAIN (Pain) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), PAIN (Pain) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), PAIN (Pain) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Medicals conditions; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Medicals conditions) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Medicals conditions). At the time of the report, ADVERSE REACTION (Medicals conditions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash erythematous
Clinical narrative: tiny spots on her arm where they were itchy, hurt, and red; tiny spots on her arm where they were itchy, hurt, and red.; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), RASH ERYTHEMATOUS (tiny spots on her arm where they were itchy, hurt, and red) and PRURITUS (tiny spots on her arm where they were itchy, hurt, and red.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received eleventh dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 30-Jan-2021, the patient experienced RASH ERYTHEMATOUS (tiny spots on her arm where they were itchy, hurt, and red) and PRURITUS (tiny spots on her arm where they were itchy, hurt, and red.). At the time of the report, PAIN IN EXTREMITY (arm was sore), RASH ERYTHEMATOUS (tiny spots on her arm where they were itchy, hurt, and red) and PRURITUS (tiny spots on her arm where they were itchy, hurt, and red.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site oedema
Clinical narrative: as if someone had given her a bump; hard; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE OEDEMA (as if someone had given her a bump), INJECTION SITE MASS (hard) and INJECTION SITE ERYTHEMA (red at the injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE OEDEMA (as if someone had given her a bump), INJECTION SITE MASS (hard) and INJECTION SITE ERYTHEMA (red at the injection site). At the time of the report, INJECTION SITE OEDEMA (as if someone had given her a bump), INJECTION SITE MASS (hard) and INJECTION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ice at the injection site.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: No new information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Achiness and soreness in arm at the injection site; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Achiness and soreness in arm at the injection site) and MYALGIA (Muscle pain) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Achiness and soreness in arm at the injection site) and MYALGIA (Muscle pain). At the time of the report, VACCINATION SITE PAIN (Achiness and soreness in arm at the injection site) and MYALGIA (Muscle pain) had not resolved.            No concomitant medicines were reported. No treatment information were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Swelling, Vaccination site mass, Vaccination site reaction
Clinical narrative: swelling; 3 bumpy, lumps; arm had strange reaction; pain; had little chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), VACCINATION SITE MASS (3 bumpy, lumps), VACCINATION SITE REACTION (arm had strange reaction), PAIN (pain) and CHILLS (had little chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced SWELLING (swelling), VACCINATION SITE MASS (3 bumpy, lumps), VACCINATION SITE REACTION (arm had strange reaction), PAIN (pain) and CHILLS (had little chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, SWELLING (swelling), VACCINATION SITE MASS (3 bumpy, lumps), VACCINATION SITE REACTION (arm had strange reaction), PAIN (pain) and CHILLS (had little chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: "nodded off"; "kind of tired" AND felt a stronger tiredness"; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness") in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack in May 2017. Concurrent medical conditions included Penicillin allergy and Uterine cancer. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN and GABAPENTIN for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness"). At the time of the report, SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling hot, Hyperhidrosis, Pyrexia
Clinical narrative: Red bump; Swollen red bump size of baseball; Felt sweaty; Felt warm; Fever; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball), HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and FATIGUE (Felt tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (Felt tired). On 30-Jan-2021, the patient experienced ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball), HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and PYREXIA (Fever). On 31-Jan-2021, HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and PYREXIA (Fever) had resolved. At the time of the report, ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient uses unspecified COPD inhalers for treating his current condition COPD which concomitants.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Red bump; Swollen red bump size of baseball; Felt sweaty; Felt warm; Fever; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball), HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and FATIGUE (Felt tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (Felt tired). On 30-Jan-2021, the patient experienced ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball), HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and PYREXIA (Fever). On 31-Jan-2021, HYPERHIDROSIS (Felt sweaty), FEELING HOT (Felt warm) and PYREXIA (Fever) had resolved. At the time of the report, ERYTHEMA (Red bump), SWELLING (Swollen red bump size of baseball) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient uses unspecified COPD inhalers for treating his current condition COPD which concomitants.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Oropharyngeal pain, Pyrexia
Clinical narrative: SORE THROAT; CONGESTION; COUGH; FEVER; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER). At the time of the report, OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swollen Arm on injection site; Redness Around (Injection Site); Muscle Ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen Arm on injection site), VACCINATION SITE ERYTHEMA (Redness Around (Injection Site)) and MYALGIA (Muscle Ache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swollen Arm on injection site), VACCINATION SITE ERYTHEMA (Redness Around (Injection Site)) and MYALGIA (Muscle Ache). At the time of the report, VACCINATION SITE SWELLING (Swollen Arm on injection site), VACCINATION SITE ERYTHEMA (Redness Around (Injection Site)) and MYALGIA (Muscle Ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Musculoskeletal stiffness, Pain
Clinical narrative: Stiffness in arm; Pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PAIN (Pain) and FATIGUE (Fatigue) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (Pain) and FATIGUE (Fatigue). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in arm). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PAIN (Pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness at the injection site for over a week after getting the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site for over a week after getting the first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site for over a week after getting the first dose). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site for over a week after getting the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: His arm was quite painful; Aches of the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (His arm was quite painful) and PAIN (Aches of the arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (His arm was quite painful) and PAIN (Aches of the arm). The patient was treated with IBUPROFEN on 30-Jan-2021 for Pain in arm, at a dose of Took 2 tablets. At the time of the report, PAIN IN EXTREMITY (His arm was quite painful) and PAIN (Aches of the arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Event outcome received, patient has recovered and does not wish to be followed up
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: Severe stomach cramp; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Severe stomach cramp) and DIARRHOEA (Diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome (Occasion IBS like symptoms but not constantly).    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Severe stomach cramp) and DIARRHOEA (Diarrhea). At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach cramp) and DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included loperamide.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), NAUSEA (nausea), HEADACHE (slight headache), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 29-Jan-2021, the patient experienced FATIGUE (fatigue), NAUSEA (nausea), HEADACHE (slight headache), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). On 30-Jan-2021, FATIGUE (fatigue), NAUSEA (nausea), HEADACHE (slight headache), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: Ear ache; Sore throat; swelling of lymph nodes on left side; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Ear ache), OROPHARYNGEAL PAIN (Sore throat), LYMPHADENOPATHY (swelling of lymph nodes on left side) and HEADACHE (Headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced EAR PAIN (Ear ache), OROPHARYNGEAL PAIN (Sore throat), LYMPHADENOPATHY (swelling of lymph nodes on left side) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, EAR PAIN (Ear ache), OROPHARYNGEAL PAIN (Sore throat), LYMPHADENOPATHY (swelling of lymph nodes on left side) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included were tremor medications.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Gastrointestinal sounds abnormal
Clinical narrative: Prolonged type of diarrhea that I have never experienced before; Experienced stomach pain; Stomach rumbling; Diarrhea is strange, bad and explosive; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Prolonged type of diarrhea that I have never experienced before), ABDOMINAL PAIN UPPER (Experienced stomach pain), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach rumbling) and DIARRHOEA (Diarrhea is strange, bad and explosive) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DIARRHOEA (Prolonged type of diarrhea that I have never experienced before), ABDOMINAL PAIN UPPER (Experienced stomach pain), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach rumbling) and DIARRHOEA (Diarrhea is strange, bad and explosive). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Prolonged type of diarrhea that I have never experienced before), ABDOMINAL PAIN UPPER (Experienced stomach pain), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach rumbling) and DIARRHOEA (Diarrhea is strange, bad and explosive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Myalgia, Myositis, Swelling
Clinical narrative: new swollen spot appeared, 2 inches long and 1 inch wide; bicep area was warm and inflamed, 1 inch wide and 2 inches long; left arm was sore and uncomfortable; left arm was sore and uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long), SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide), LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MESALAMINE for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable). On 02-Feb-2021, the patient experienced MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long). On 03-Feb-2021, the patient experienced SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long), SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide), LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On  the night of 02 Feb 2021 patient took diphenhydramine, however by the morning of 03feb2021 the "inflamed area had doubled in size."
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site warmth
Clinical narrative: has fever in it/it lasted over 2 weeks; vaccination site reaction (Moderna arm); redness, big round bull size; A spontaneous report was received from a Consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events covid arm, redness, big round bull size, has fever in it, it lasted over 2 weeks.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) intramuscularly for prophylaxis of COVID-19 infection.  On 13 Jan 2021, the patient experienced the events covid arm. redness, big round bull size, has fever in it, it lasted over 2 weeks.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, covid arm, On an unknown date the outcome of events, redness, On an unknown date the outcome of events, big round bull size, On an unknown date the outcome of events, has fever in it, On an unknown date the outcome of events, it lasted over 2 weeks was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid-19) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced COVID-19 (Tested positive for covid-19). The patient was treated with BAMLANIVIMAB for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive for covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, SARS-CoV-2 test: covid-19 (Positive) COVID-19.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: both of his arms are itchy; A little bit red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (both of his arms are itchy) and VACCINATION SITE ERYTHEMA (A little bit red) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (both of his arms are itchy) and VACCINATION SITE ERYTHEMA (A little bit red). At the time of the report, PRURITUS (both of his arms are itchy) and VACCINATION SITE ERYTHEMA (A little bit red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included an unspecified cholesterol medicine.  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received on 09JUL2021,  updates reporters contact information.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Bite, Influenza like illness, Pruritus, Pyrexia, Rash
Clinical narrative: itching everywhere; rash on back of right legs/spreading on the back of leg; fever; bad flu-like symptoms; mosquito-bite-like bump on back of leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (bad flu-like symptoms), BITE (mosquito-bite-like bump on back of leg), PRURITUS (itching everywhere), RASH (rash on back of right legs/spreading on the back of leg) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced BITE (mosquito-bite-like bump on back of leg). On 02-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (bad flu-like symptoms) and PYREXIA (fever). On 03-Feb-2021, the patient experienced PRURITUS (itching everywhere) and RASH (rash on back of right legs/spreading on the back of leg). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE ARROW) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (bad flu-like symptoms), BITE (mosquito-bite-like bump on back of leg), PRURITUS (itching everywhere), RASH (rash on back of right legs/spreading on the back of leg) and PYREXIA (fever) outcome was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Poor quality sleep, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Poor sleep) and PYREXIA (Fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L00A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced POOR QUALITY SLEEP (Poor sleep) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, qid. On 28-Jan-2021, PYREXIA (Fever) had resolved. At the time of the report, POOR QUALITY SLEEP (Poor sleep) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Hair falling; Strong Headache; Fever; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair falling), HEADACHE (Strong Headache), PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0371C20A) for COVID-19 vaccination.     no specified medical history was reported.  Concomitant products included VITAMIN 15 and BIOTIN for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced ALOPECIA (Hair falling), HEADACHE (Strong Headache), PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, ALOPECIA (Hair falling), HEADACHE (Strong Headache), PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Urticaria
Clinical narrative: Welt length of an arm and width wider than a dollar bill; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness at the injection site) and URTICARIA (Welt length of an arm and width wider than a dollar bill) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE PAIN (Soreness at the injection site) and URTICARIA (Welt length of an arm and width wider than a dollar bill). At the time of the report, INJECTION SITE PAIN (Soreness at the injection site) and URTICARIA (Welt length of an arm and width wider than a dollar bill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash, Skin reaction, Swelling
Clinical narrative: Swelling; Tender to touch; Achy when I raised my arm; Itching; delayed side effect; Rash/round rash about 3 by 4 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide) and PRURITUS (Itching) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included CICLOSPORIN (RESTASIS) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide), PRURITUS (Itching) and SKIN REACTION (delayed side effect). At the time of the report, SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide) and PRURITUS (Itching) had resolved and SKIN REACTION (delayed side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Swelling; Tender to touch; Achy when I raised my arm; Itching; delayed side effect; Rash/round rash about 3 by 4 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide) and PRURITUS (Itching) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included CICLOSPORIN (RESTASIS) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide), PRURITUS (Itching) and SKIN REACTION (delayed side effect). At the time of the report, SWELLING (Swelling), TENDERNESS (Tender to touch), PAIN IN EXTREMITY (Achy when I raised my arm), RASH (Rash/round rash about 3 by 4 inches wide) and PRURITUS (Itching) had resolved and SKIN REACTION (delayed side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: sore arm; some tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) and FATIGUE (some tiredness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis rheumatoid. Concomitant products included METHOTREXATE SODIUM (METHOTREXATE ACCORD) for Arthritis rheumatoid.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm) and FATIGUE (some tiredness). At the time of the report, VACCINATION SITE PAIN (sore arm) and FATIGUE (some tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site scar
Clinical narrative: it left a scar with death tissues of skin with red fluxes around it; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SCAR (it left a scar with death tissues of skin with red fluxes around it) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SCAR (it left a scar with death tissues of skin with red fluxes around it). At the time of the report, VACCINATION SITE SCAR (it left a scar with death tissues of skin with red fluxes around it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.